Join Free For Buyer|Sign In

Professional Online Trade Platform for API, Preparation and Pharmaceutical Machinery and Equipment_EN-CPhI.cn

2019NEX

You are here:Home >> product >> Active Pharmaceutical Ingredients >> Other Active Pharmaceutical Ingredients >> darunavir

darunavir

darunavir

Region: Jiangsu
Minimum Order Quantity:
Monthly Production Capacity:
Send Inquiry Add to Cart
Detailed Description
  • Main Sales Markets: North America, Central/South America, Western Europe, Eastern Europe, Australasia, Asia, Middle East, Africa
  • Sample Provided: no

Darunavir (brand name Prezista, formerly known as TMC114) is a protease inhibitor drug used to treat HIV infection. Prezista is an OARAC recommended treatment option for treatment-naïve and treatment-experienced adults and adolescents.[1] Developed by pharmaceutical company Tibotec, darunavir is named after Arun K. Ghosh, the chemistry professor who discovered the molecule at the University of Illinois at Chicago.[2] It was approved by the Food and Drug Administration (FDA) on June 23, 2006.[3]

Address: Taizhou,Jiangsu,China

City: Taizhou

Contact: Chen Bin

TEL: -523-86818997

Fax: -523-86818697

Send Inquiry
Previous Other Active Pharmaceutical Ingredients Next
Follow Us
CPhI Online Trade Platform: Worldwide|English|中国站
Customer Service:  86-400 610 1188 (9: 00-18: 00, Mon-Fri)
About Us| Contact Us| Terms of Services| Privacy Policy| Intellectual Property Statement| Links | Site Map
Copyright 2006-20 Shanghai UBM Sinoexpo International Exhibition Co Ltd (All Rights Reserved). ICP 05034851-53
web对话
live chat
客服对话